» Articles » PMID: 38132394

Anastomosis Complications After Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2023 Dec 22
PMID 38132394
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sleeve lobectomy with bronchoplasty is a safe surgical technique for the management of lung cancer and endobronchial localization of extrapulmonary cancers. However, anastomotic complications can occur, and treatment strategies are not standardized.

Methods: Data from 280 patients subjected to bronchoplasty were retrospectively analyzed, focusing on surgical techniques, anastomotic complications, and their management. Multivariate analysis was performed, and Kaplan-Meier curves were used to determine survival.

Results: Ninety percent of 280 surgeries were for lung cancer. Anastomotic complications occurred in 6.42% of patients: late stenosis in 3.92% and broncho-pleural fistula in 1.78%. The median survival was 65.90 months (95% CI = 41.76-90.97), with no difference ( = 0.375) for patients with (51.28 months) or without (71.03 months) anastomotic complications. Mortality at 30 days was higher with anastomotic complications (16.7% vs. 3%, = 0.014). Multivariable analysis confirmed pathological stage (N+) as a risk factor for anastomotic complications ( = 0.016). Our mortality (3.93%) and morbidity rate (41.78%) corresponded to recent series results.

Conclusions: In our experience, surgery is preferred to avoid life-threatening complications in bronchopleural fistulas. Bronchoscopic balloon dilatation is preferred for benign strictures. The nodal stage is related to complications ( = 0.0014), reflecting the aggressiveness of surgery, which requires extended radical lymphadenectomy.

References
1.
Casiraghi M, Maisonneuve P, Piperno G, Bellini R, Brambilla D, Petrella F . Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer. Semin Thorac Cardiovasc Surg. 2017; 29(2):233-241. DOI: 10.1053/j.semtcvs.2017.02.001. View

2.
Terzi A, Lonardoni A, Falezza G, Furlan G, Scanagatta P, Pasini F . Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg. 2002; 21(5):888-93. DOI: 10.1016/s1010-7940(02)00085-4. View

3.
Ferguson M, Lehman A . Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg. 2003; 76(6):1782-8. DOI: 10.1016/s0003-4975(03)01243-8. View

4.
Storelli E, Tutic M, Kestenholz P, Schneiter D, Opitz I, Hillinger S . Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg. 2012; 42(1):77-81. DOI: 10.1093/ejcts/ezr291. View

5.
Gonzalez M, Litzistorf Y, Krueger T, Popeskou S, Matzinger O, Ris H . Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer. Ann Thorac Surg. 2013; 96(1):247-52. DOI: 10.1016/j.athoracsur.2013.04.009. View